Polymyositis after interferon β treatment of chronic hepatitis type C

Clinical Neurology

Volumn 36, Issue 1, 1996, Pages 22-24

  Iguchi, Hiroaki ^a   Kishi, Masahiko ^a   Fujioka, Toshiki ^a   Wakata, Nobuo ^a   Kinoshita, Masao ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

autoimmune disease; chronic hepatitis type C; interferon ; polymyositis

Indexed keywords

BETA INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; ELECTROMYOGRAM; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MUSCLE ATROPHY; MUSCLE WEAKNESS; POLYMYOSITIS;

CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMANS; INTERFERON-BETA; MIDDLE AGED; POLYMYOSITIS;

EID: 0029902756     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Pestka S, Langer JA, Zoon KC, et al: Interferons and their actions. Ann Rev Biochem 56: 727-777, 1987
2. Ronnblom LE, Alm GV, Oberg KE: Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Int Med 227: 207-210, 1990
3. Burman P, Totterman TH, Oberg K, et al: Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 63: 1086-1090, 1986
4. Pangalis GA, Griva E: Recombinant alfa-2b-interferon therapy in untreated stages A and B chronic lymphocytic leukemia. Cancer 61: 869-872, 1988
5. Matsuya M, Abe T, Tosaka M, et al: The first case of polymyositis associated with interferon therapy. Int Med 33: 806-808, 1994
6. Aral H, Tanaka M, Ohta K, et al: Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet 2, 345: 582, 1995
7. Isenberg DA, Rowe D, Shearer M, et al: Localization of interferon and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 63: 450-458, 1986